A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma (Q33376462)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma |
scientific article |
Statements
1 reference
A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma (English)
1 reference
Kwhanmien Kim
1 reference
Jeeyun Lee
1 reference
Young-Hyuck Im
1 reference
Eun Yoon Cho
1 reference
Yong Sang Hong
1 reference
Hyo Rak Lee
1 reference
Hyo Song Kim
1 reference
Mi-Jin Kim
1 reference
Won Ki Kang
1 reference
Keunchil Park
1 reference
Young Mog Shim
1 reference
31 August 2007
1 reference
1 reference
62
1 reference
77-84
1 reference
Identifiers
1 reference
1 reference